Levothyroxine/Liothyronine Combination Therapy and Quality of Life: Is It All about Weight Loss? | Zendy

Luba Freja Michaelsson | Zendy; Jeppe Lerche la Cour | Zendy; Bjarke Borregaard Medici | Zendy; Torquil Watt | Zendy; Jens Faber | Zendy; Birte Nygaard | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Levothyroxine/Liothyronine Combination Therapy and Quality of Life: Is It All about Weight Loss?

Author(s) -

Luba Freja Michaelsson,

Jeppe Lerche la Cour,

Bjarke Borregaard Medici,

Torquil Watt,

Jens Faber,

Birte Nygaard

Publication year - 2018

Publication title -

european thyroid journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.23

H-Index - 10

eISSN - 2235-0802

pISSN - 2235-0640

DOI - 10.1159/000490383

Subject(s) - medicine , levothyroxine , weight loss , quality of life (healthcare) , combination therapy , thyroid function , cohort , pediatrics , weight gain , thyroid function tests , thyroid , endocrinology , body weight , obesity , nursing

According to one hypothesis, the popularity of levothyroxine (L-T 4 )/liothyronine (L-T 3 ) combination therapy relates to weight loss. The purpose of this study was to detect a possible correlation between thyroid-related quality of life (QoL) and weight loss in hypothyroid patients switched from L-T 4 monotherapy to L-T 4 /L-T 3 combination therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research